DIPLOMAT PHARMACY INC's ticker is DPLO and the CUSIP is 25456K101. A total of 188 filers reported holding DIPLOMAT PHARMACY INC in Q3 2016. The put-call ratio across all filers is 0.77 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $276,000 | -83.5% | 21,950 | -63.2% | 0.13% | -82.5% |
| Q3 2016 | $1,670,000 | -24.8% | 59,650 | -6.0% | 0.72% | -31.4% |
| Q2 2016 | $2,220,000 | +20.3% | 63,430 | -5.9% | 1.05% | +13.9% |
| Q1 2016 | $1,846,000 | -15.9% | 67,380 | +5.1% | 0.92% | -13.8% |
| Q4 2015 | $2,194,000 | – | 64,130 | – | 1.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 7,036,670 | $42,853,000 | 1.54% |
| ARMISTICE CAPITAL, LLC | 3,200,000 | $19,488,000 | 1.23% |
| STEPHENS INC /AR/ | 6,600,015 | $40,194,000 | 0.91% |
| S&T BANK/PA | 610,367 | $3,718,000 | 0.82% |
| Rhenman & Partners Asset Management AB | 1,203,405 | $7,329,000 | 0.81% |
| Matarin Capital Management, LLC | 701,445 | $4,272,000 | 0.30% |
| Investors Research Corp | 89,727 | $546,000 | 0.28% |
| Advisory Services Network, LLC | 598,802 | $3,647,000 | 0.22% |
| FCG ADVISORS, LLC | 34,000 | $207,000 | 0.06% |
| EVERENCE CAPITAL MANAGEMENT INC | 52,730 | $321,000 | 0.05% |